MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clgc.2019.10.021

Медицинская библиотека · Clinical genitourinary cancer · 2019

Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer.

D'Andrea David, Soria Francesco, Abufaraj Mohammad, Pones Mario, Gontero Paolo, Machado André T, Waksman Ricardo, Enikeev Dmitry V, Glybochko Petr V, Adonias Sanarelly Pires, Nahas William Carlos, Shariat Shahrokh F, Chade Daher C

Сравнительное исследованиеСтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

The purpose of this study was to compare the efficacy of 2 bacillus Calmette-Guérin (BCG) strains, BCG-Tice and BCG-Moreau, in the treatment of non-muscle-invasive bladder cancer (NMIBC).

MATERIALS AND

METHODS

We retrospectively reviewed clinical data from patients treated with BCG for NMIBC at 3 academic centers. Inverse probability of treatment weighting (IPTW)-adjusted Kaplan-Meier curves and Cox proportional hazards regression analyses were used to compare recurrence-free (RFS) and progression-free survival (PFS) of patients in the 2 treatment groups. In addition, we performed exploratory analyses of treatment effect according to the receipt of adequate BCG treatment, high-risk disease, age, gender, smoking status, pathologic stage, and pathologic grade.

RESULTS

A total of 321 (48.6%) patients were treated with BCG-Tice and 339 (51.4%) with BCG-Moreau. IPTW-adjusted Cox proportional hazard regression analysis did not show a difference in RFS (hazard ratio, 0.88; 95% confidence interval, 0.56-1.38; P = .58) or PFS (hazard ratio, 0.55; 95% confidence interval, 0.25-1.21, P = .14) between BCG-Tice and BCG-Moreau. On subgroup analyses, we could not identify an association of BCG strain with outcomes.

CONCLUSIONS

There was no difference in RFS and PFS between BCG-Tice and BCG-Moreau strains in the adjuvant treatment of NMIBC. However, we confirmed the importance of maintenance therapy for achieving a sustainable response in patients with intermediate- and high-risk NMIBC.

Для цитирования: D'Andrea David, Soria Francesco, Abufaraj Mohammad, Pones Mario, Gontero Paolo, Machado André T, Waksman Ricardo, Enikeev Dmitry V, Glybochko Petr V, Adonias Sanarelly Pires, Nahas William Carlos, Shariat Shahrokh F, Chade Daher C. Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer.. Clinical genitourinary cancer. 2019. DOI: 10.1016/j.clgc.2019.10.021.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.